Data Year:

For its 2025 fiscal year, INTUITIVE SURGICAL INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In MFG Durable industry
Gary S. Guthart Ph.D.
Executive Chair of the Board of Directors
Total Compensation $18,094,937 View details Pay Rank By Title In MFG Durable industry #2 View more
David J. Rosa
Chief Executive Officer
Total Compensation $20,997,480 View details Pay Rank By Title In MFG Durable industry #57 View more
Jamie E. Samath
Executive Vice President, Chief Financial Officer and Enterprise Technology Leader
Total Compensation $8,396,045 View details Pay Rank By Title In MFG Durable industry #41 View more
Henry L. Charlton
Executive Vice President and Chief Commercial and Marketing Officer
Total Compensation $6,240,703 View details Pay Rank By Title In MFG Durable industry #43 View more
Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
Total Compensation $5,539,390 View details Pay Rank By Title In MFG Durable industry #16 View more
Gary H. Loeb
Executive Vice President and Chief Legal and Compliance Officer
Total Compensation $5,590,211 View details Pay Rank By Title In MFG Durable industry #48 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at INTUITIVE SURGICAL INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. INTUITIVE SURGICAL INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. INTUITIVE SURGICAL INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Gary S. Guthart Ph.D.
Executive Chair of the Board of Directors
Total Cash $1,752,406 Equity $15,954,662 Other $387,869 $18,094,937
David J. Rosa
Chief Executive Officer
Total Cash $2,232,609 Equity $18,674,872 Other $89,999 $20,997,480
Jamie E. Samath
Executive Vice President, Chief Financial Officer and Enterprise Technology Leader
Total Cash $1,469,816 Equity $6,914,229 Other $12,000 $8,396,045
Henry L. Charlton
Executive Vice President and Chief Commercial and Marketing Officer
Total Cash $1,441,840 Equity $4,786,863 Other $12,000 $6,240,703
Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
Total Cash $996,593 Equity $4,520,797 Other $22,000 $5,539,390
Gary H. Loeb
Executive Vice President and Chief Legal and Compliance Officer
Total Cash $1,323,480 Equity $4,254,731 Other $12,000 $5,590,211
For its 2025 fiscal year, INTUITIVE SURGICAL INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
David J. Rosa CEO Pay $18,275,861 Median Employee Pay $124,131 CEO Pay Ratio 147:1
For its 2024 fiscal year, INTUITIVE SURGICAL INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Alan J. Levy, Ph.D. Total Cash $28,333
Amal M. Johnson Total Cash $365,736
Amy L. Ladd, M.D. Total Cash $355,736
Craig H. Barratt, Ph.D. Total Cash $466,664
Don R. Kania, Ph.D. Total Cash $30,000
Jami Dover Nachtsheim Total Cash $361,569
Joseph C. Beery Total Cash $354,903
Keith R. Leonard, Jr. Total Cash $358,236
Lewis Chew Total Cash $339,069
Mark J. Rubash Total Cash $362,403
Monica P. Reed, M.D. Total Cash $355,736
Sreelakshmi Kolli Total Cash $354,069
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.